Alfonso Serrano del Valle

794 total citations
9 papers, 466 citations indexed

About

Alfonso Serrano del Valle is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Alfonso Serrano del Valle has authored 9 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Alfonso Serrano del Valle's work include Multiple Myeloma Research and Treatments (3 papers), Immune Cell Function and Interaction (3 papers) and Phagocytosis and Immune Regulation (2 papers). Alfonso Serrano del Valle is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Immune Cell Function and Interaction (3 papers) and Phagocytosis and Immune Regulation (2 papers). Alfonso Serrano del Valle collaborates with scholars based in Spain, United States and Netherlands. Alfonso Serrano del Valle's co-authors include Isabel Marzo, Alberto Anel, Javier Naval, Andrés Hidalgo, Jaime García‐Prieto, Inés García‐Lunar, Georgiana Crainiciuc, Valentı́n Fuster, Borja Ibáñez and José M. García‐Ruiz and has published in prestigious journals such as Circulation, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

Alfonso Serrano del Valle

8 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Serrano del Valle Spain 6 168 159 137 79 66 9 466
Shundong Ji China 13 122 0.7× 227 1.4× 60 0.4× 34 0.4× 24 0.4× 35 500
Chiara Barozzi Italy 13 130 0.8× 224 1.4× 29 0.2× 104 1.3× 27 0.4× 25 534
Luo Zhang China 12 75 0.4× 196 1.2× 127 0.9× 25 0.3× 41 0.6× 28 454
Mansooreh Jaberipour Iran 14 208 1.2× 232 1.5× 117 0.9× 14 0.2× 25 0.4× 31 592
Ofer Elhanani Israel 9 144 0.9× 275 1.7× 104 0.8× 56 0.7× 7 0.1× 14 527
Juan Cueva Spain 17 319 1.9× 256 1.6× 43 0.3× 15 0.2× 37 0.6× 41 633
Qingqiang Tu China 5 75 0.4× 488 3.1× 136 1.0× 23 0.3× 30 0.5× 10 668
Guoxu Zheng China 15 209 1.2× 421 2.6× 215 1.6× 28 0.4× 9 0.1× 29 793
Jinhua Piao China 12 48 0.3× 339 2.1× 57 0.4× 23 0.3× 92 1.4× 32 606
Alexander Jorge Cortez Poland 10 238 1.4× 332 2.1× 91 0.7× 20 0.3× 10 0.2× 24 696

Countries citing papers authored by Alfonso Serrano del Valle

Since Specialization
Citations

This map shows the geographic impact of Alfonso Serrano del Valle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Serrano del Valle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Serrano del Valle more than expected).

Fields of papers citing papers by Alfonso Serrano del Valle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Serrano del Valle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Serrano del Valle. The network helps show where Alfonso Serrano del Valle may publish in the future.

Co-authorship network of co-authors of Alfonso Serrano del Valle

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Serrano del Valle. A scholar is included among the top collaborators of Alfonso Serrano del Valle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Serrano del Valle. Alfonso Serrano del Valle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Valle, Alfonso Serrano del, et al.. (2024). Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow. Methods in cell biology. 189. 189–206.
2.
Cuenca, Marta, Alfonso Serrano del Valle, Gemma Azaceta, et al.. (2023). Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐XL in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients. Molecular Oncology. 17(12). 2507–2525. 2 indexed citations
3.
Valle, Alfonso Serrano del, Gemma Azaceta, Luis Palomera, et al.. (2022). Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis. OncoImmunology. 11(1). 2141973–2141973. 7 indexed citations
4.
Valle, Alfonso Serrano del, et al.. (2021). Future prospects for mitosis-targeted antitumor therapies. Biochemical Pharmacology. 190. 114655–114655. 34 indexed citations
5.
Valle, Alfonso Serrano del, Javier Naval, Alberto Anel, & Isabel Marzo. (2020). Novel Forms of Immunomodulation for Cancer Therapy. Trends in cancer. 6(6). 518–532. 20 indexed citations
6.
Valle, Alfonso Serrano del, Alberto Anel, Javier Naval, & Isabel Marzo. (2019). Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. Frontiers in Cell and Developmental Biology. 7. 50–50. 156 indexed citations
7.
García‐Prieto, Jaime, Rocío Villena-Gutiérrez, Monica Gómez, et al.. (2017). Neutrophil stunning by metoprolol reduces infarct size. Nature Communications. 8(1). 14780–14780. 155 indexed citations
8.
Fernández‐Gallardo, Jacob, Óscar Gonzalo, Víctor Mangas‐Sanjuan, et al.. (2015). Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties. Journal of Medicinal Chemistry. 58(15). 5825–5841. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026